Bioventix PLC | Cash Flow

Fiscal year is July-June. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,809.40
2,202.10
3,097.60
3,494.40
4,922.30
5,663.30
Depreciation, Depletion & Amortization
44.30
30.90
45.50
41.70
39.50
58.50
Other Funds
256.60
134.70
711.10
283.70
377.40
763.40
Funds from Operations
1,597.10
2,098.40
2,432.00
3,819.80
4,582.50
6,495.30
Changes in Working Capital
513.10
467.80
278.90
581.30
570.00
539.40
Net Operating Cash Flow
1,084.00
1,630.60
2,153.20
3,238.50
4,012.50
5,955.90
Capital Expenditures
21.30
1.90
113.80
21.00
21.70
Sale of Fixed Assets & Businesses
-
-
0.70
-
-
Purchase/Sale of Investments
-
-
-
43.30
152.20
Net Investing Cash Flow
21.30
1.90
113.10
64.30
173.90
Cash Dividends Paid - Total
656.30
921.50
1,282.00
1,924.40
3,373.10
Net Financing Cash Flow
656.30
862.70
1,261.00
1,924.40
3,052.00
Net Change in Cash
406.40
766.00
779.10
1,249.80
786.50
Free Cash Flow
1,062.70
1,628.70
2,039.40
3,217.50
3,990.80
Deferred Taxes & Investment Tax Credit
-
-
-
-
1.80
10.10
Change in Capital Stock
-
58.70
21.00
-
321.10

About Bioventix

View Profile
Address
7 Romans Business Park
Farnham Surrey GU9 7SX
United Kingdom
Employees -
Website http://bioventix.com
Updated 07/08/2019
Bioventix Plc engages in the development and supply of antibodies. It is involved in the development and manufacture of sheep monoclonal antibodies for use in the fields of clinical diagnostics and drugs of abuse testing. The company was founded on October 7, 2003 and is headquartered in Farnham, the United Kingdom.